Rodent spinal cord demyelination models

Sarah C. Jernigan; Yi Ping Zhang; Christopher B. Shields; Scott R. Whittemore

doi:10.1007/978-1-60327-185-1_40

Rodent spinal cord demyelination models

Sarah C. Jernigan, Yi Ping Zhang, Christopher B. Shields, Scott R. Whittemore

Neurological Surgery

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

Demyelination is a significant component of contusive spinal cord injury as well as in multiple sclerosis. As such, remyelination, either by endogenous or grafted exogenous myelinating cells is a viable therapeutic target to restore function. To assess specific approaches to facilitate functional remyelination in vivo, appropriate injury models are needed. This chapter will discuss the strengths and weaknesses of a number of demyelinating lesions of the spinal cord and provide guidelines for choosing which model best suits which experimental condition. Step by step procedures for both creating and assessing the lesion will be provided.

Original language	English (US)
Title of host publication	Animal Models of Acute Neurological Injuries
Publisher	Humana Press
Pages	471-478
Number of pages	8
ISBN (Print)	9781603271844
DOIs	https://doi.org/10.1007/978-1-60327-185-1_40
State	Published - Dec 1 2009

Keywords

Cuprizone
Demyelination
Ethidium bromide
Lysolethicin
Spinal cord injury

ASJC Scopus subject areas

Neuroscience(all)
Agricultural and Biological Sciences(all)

Access to Document

10.1007/978-1-60327-185-1_40

Fingerprint Dive into the research topics of 'Rodent spinal cord demyelination models'. Together they form a unique fingerprint.

Cite this

Jernigan, S. C., Zhang, Y. P., Shields, C. B., & Whittemore, S. R. (2009). Rodent spinal cord demyelination models. In Animal Models of Acute Neurological Injuries (pp. 471-478). Humana Press. https://doi.org/10.1007/978-1-60327-185-1_40

@inbook{d5d4c3e4c38146de8308a078bd7dac4a,

title = "Rodent spinal cord demyelination models",

abstract = "Demyelination is a significant component of contusive spinal cord injury as well as in multiple sclerosis. As such, remyelination, either by endogenous or grafted exogenous myelinating cells is a viable therapeutic target to restore function. To assess specific approaches to facilitate functional remyelination in vivo, appropriate injury models are needed. This chapter will discuss the strengths and weaknesses of a number of demyelinating lesions of the spinal cord and provide guidelines for choosing which model best suits which experimental condition. Step by step procedures for both creating and assessing the lesion will be provided.",

keywords = "Cuprizone, Demyelination, Ethidium bromide, Lysolethicin, Spinal cord injury",

author = "Jernigan, {Sarah C.} and Zhang, {Yi Ping} and Shields, {Christopher B.} and Whittemore, {Scott R.}",

year = "2009",

month = dec,

day = "1",

doi = "10.1007/978-1-60327-185-1_40",

language = "English (US)",

isbn = "9781603271844",

pages = "471--478",

booktitle = "Animal Models of Acute Neurological Injuries",

publisher = "Humana Press",

}

TY - CHAP

T1 - Rodent spinal cord demyelination models

AU - Jernigan, Sarah C.

AU - Zhang, Yi Ping

AU - Shields, Christopher B.

AU - Whittemore, Scott R.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Demyelination is a significant component of contusive spinal cord injury as well as in multiple sclerosis. As such, remyelination, either by endogenous or grafted exogenous myelinating cells is a viable therapeutic target to restore function. To assess specific approaches to facilitate functional remyelination in vivo, appropriate injury models are needed. This chapter will discuss the strengths and weaknesses of a number of demyelinating lesions of the spinal cord and provide guidelines for choosing which model best suits which experimental condition. Step by step procedures for both creating and assessing the lesion will be provided.

AB - Demyelination is a significant component of contusive spinal cord injury as well as in multiple sclerosis. As such, remyelination, either by endogenous or grafted exogenous myelinating cells is a viable therapeutic target to restore function. To assess specific approaches to facilitate functional remyelination in vivo, appropriate injury models are needed. This chapter will discuss the strengths and weaknesses of a number of demyelinating lesions of the spinal cord and provide guidelines for choosing which model best suits which experimental condition. Step by step procedures for both creating and assessing the lesion will be provided.

KW - Cuprizone

KW - Demyelination

KW - Ethidium bromide

KW - Lysolethicin

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=84900588826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900588826&partnerID=8YFLogxK

U2 - 10.1007/978-1-60327-185-1_40

DO - 10.1007/978-1-60327-185-1_40

M3 - Chapter

AN - SCOPUS:84900588826

SN - 9781603271844

SP - 471

EP - 478

BT - Animal Models of Acute Neurological Injuries

PB - Humana Press

ER -